Liyuan Woo - Aug 10, 2023 Form 4 Insider Report for Beauty Health Co (SKIN)

Role
Former Chief Financial Officer
Signature
/s/ Paul Bokota, Attorney-in-Fact for Liyuan Woo
Stock symbol
SKIN
Transactions as of
Aug 10, 2023
Transactions value $
$0
Form type
4
Date filed
8/11/2023, 06:46 PM
Previous filing
Apr 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SKIN Stock Options (right to buy) Disposed to Issuer -372K -100% 0 Aug 10, 2023 Common Stock 372K $12.85 Direct F1
transaction SKIN Stock Options (right to buy) Award +372K 372K Aug 10, 2023 Common Stock 372K $12.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Liyuan Woo is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The transaction involves an amendment of an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 6, 2021 and represented a grant of 744,000 shares of common stock underlying the option under the issuer's 2021 Incentive Award Plan (the "Plan"). As of Aug 10, 2023, the date of the Reporting Person's separation from the issuer (the "Separation Date"), 372,000 shares underlying the option, had vested (the "Vested Options") and the other 372,000 shares underlying the option, had not vested (the "Unvested Options"). Under the Plan, the Unvested Options were forfeited upon separation and the Vested Options would have to be exercised within 90 days of the Separation Date. However, pursuant to the Reporting Person's separation agreement, as filed in Exhibit 10.2 to the issuer's Current Report on Form 8-K filed on Aug 9, 2023, the expiration date of the Vested Options was extended to Aug 10, 2025.